Holen Sie sich die Stockscreener-App
10.00
0.70%
-0.07
Handel nachbörslich:
13.75
3.75
+37.50%
Schlusskurs vom Vortag:
$10.07
Offen:
$10.15
24-Stunden-Volumen:
1.25M
Relative Volume:
2.98
Marktkapitalisierung:
$335.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-47.20M
KGV:
-6.3886
EPS:
-1.5653
Netto-Cashflow:
$-43.65M
1W Leistung:
-7.66%
1M Leistung:
-24.92%
6M Leistung:
+19.05%
1J Leistung:
-52.90%
1-Tages-Spanne:
$9.665
$10.28
1-Wochen-Bereich:
$9.64
$11.19
52-Wochen-Spanne:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Firmenname
Mbx Biosciences Inc
Sektor
Branche
Telefon
(317) 989-3100
Adresse
11711 N. MERIDIAN STREET, CARMEL
Vergleichen Sie MBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
10.00 | 338.29M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-08-05 | Eingeleitet | Mizuho | Outperform |
| 2025-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-10 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Eingeleitet | Guggenheim | Buy |
| 2024-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2024-10-08 | Eingeleitet | Jefferies | Buy |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
Pattern recognition hints at MBX Biosciences Inc. upside2025 Volatility Report & Consistent Growth Stock Picks - newser.com
Strategies to average down on MBX Biosciences Inc.July 2025 Momentum & Community Supported Trade Ideas - newser.com
MBX Biosciences to provide topline results from its phase 2 trial of Canvuparatide - MarketScreener
MBX Biosciences to Provide Topline Results from its Phase 2 - GlobeNewswire
Breakthrough Weekly HP Treatment Results Coming: MBX's Canvuparatide Phase 2 Data Release Monday - Stock Titan
Volume Summary: Is MBX Biosciences Inc stock forming a triangle patternJuly 2025 Volume & AI Powered Buy and Sell Recommendations - khodrobank.com
Bearish Setup: Can MBX Biosciences Inc. keep up with sector leadersJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - khodrobank.com
Institutional scanner results for MBX Biosciences Inc.Volume Spike & Daily Momentum Trading Reports - newser.com
Woodline Partners LP Acquires 268,740 Shares of MBX Biosciences, Inc. $MBX - MarketBeat
Top chart patterns to watch in MBX Biosciences Inc.Weekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Using R and stats models for MBX Biosciences Inc. forecastingEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Using AI based signals to follow MBX Biosciences Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - newser.com
How institutional ownership impacts MBX Biosciences Inc. stock2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Using RSI to spot recovery in MBX Biosciences Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Inflation Data: What is MBX Biosciences Inc. s debt to equity ratio2025 Risk Factors & Verified Short-Term Trading Plans - خودرو بانک
Market Review: Is MBX Biosciences Inc. in a consolidation phaseProduct Launch & Safe Entry Momentum Tips - khodrobank.com
Entry Recap: Does MBX Biosciences Inc. meet Warren Buffett’s criteria2025 Major Catalysts & Weekly Top Gainers Trade List - khodrobank.com
Rate Hike: Is MBX Biosciences Inc. exposed to political riskMarket Activity Report & Safe Capital Growth Tips - khodrobank.com
Using data models to predict MBX Biosciences Inc. stock movement2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
Real time breakdown of MBX Biosciences Inc. stock performanceMarket Trend Summary & Accurate Trade Setup Notifications - newser.com
Value Recap: Is MBX Biosciences Inc benefiting from interest rate changesEarnings Growth Report & Real-Time Volume Surge Alerts - khodrobank.com
Chipmakers Recap: Does MBX Biosciences Inc. meet Warren Buffett’s criteriaJuly 2025 Summary & Fast Exit/Entry Strategy Plans - khodrobank.com
MBX Biosciences (NYSE:MBX) versus Gemini Therapeutics (NASDAQ:GMTX) Financial Survey - Defense World
Trend Report: Is MBX Biosciences Inc part of any ETFJuly 2025 Update & Consistent Return Investment Signals - baoquankhu1.vn
Portfolio Update: Is MBX Biosciences Inc. exposed to political riskJuly 2025 Action & Growth Oriented Trade Recommendations - خودرو بانک
MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen - MarketBeat
Exome Asset Management LLC Makes New $982,000 Investment in MBX Biosciences, Inc. $MBX - MarketBeat
Analyzing net buyer seller activity in MBX Biosciences Inc.Market Performance Report & Stock Portfolio Risk Control - newser.com
Understanding MBX Biosciences Inc.’s price movement2025 Market Sentiment & Consistent Growth Equity Picks - newser.com
Is MBX Biosciences Inc. a candidate for recovery playQuarterly Earnings Summary & Weekly Sector Rotation Insights - newser.com
Is this a good reentry point in MBX Biosciences Inc.July 2025 Momentum & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on MBX Biosciences Inc.Weekly Risk Summary & Proven Capital Preservation Tips - Newser
Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):